Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Topokaryotyping demonstrates single cell variability and stress dependent variations in nuclear envelope associated domains.

Jurisic A, Robin C, Tarlykov P, Siggens L, Schoell B, Jauch A, Ekwall K, Sørensen CS, Lipinski M, Shoaib M, Ogryzko V.

Nucleic Acids Res. 2018 Dec 14;46(22):e135. doi: 10.1093/nar/gky818.

2.

Mammalian expression vectors for metabolic biotinylation tandem affinity tagging by co-expression in cis of a mammalian codon-optimized BirA biotin ligase.

Ioannou M, Papageorgiou DN, Ogryzko V, Strouboulis J.

BMC Res Notes. 2018 Jun 14;11(1):390. doi: 10.1186/s13104-018-3500-9.

3.

New Interactors of the Truncated EBNA-LP Protein Identified by Mass Spectrometry in P3HR1 Burkitt's Lymphoma Cells.

Chelouah S, Cochet E, Couvé S, Balkaran S, Robert A, May E, Ogryzko V, Wiels J.

Cancers (Basel). 2018 Jan 5;10(1). pii: E12. doi: 10.3390/cancers10010012.

4.

Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins.

Belyy A, Raoux-Barbot D, Saveanu C, Namane A, Ogryzko V, Worpenberg L, David V, Henriot V, Fellous S, Merrifield C, Assayag E, Ladant D, Renault L, Mechold U.

Nat Commun. 2016 Dec 5;7:13582. doi: 10.1038/ncomms13582.

5.

ZNF555 protein binds to transcriptional activator site of 4qA allele and ANT1: potential implication in Facioscapulohumeral dystrophy.

Kim E, Rich J, Karoutas A, Tarlykov P, Cochet E, Malysheva D, Mamchaoui K, Ogryzko V, Pirozhkova I.

Nucleic Acids Res. 2015 Sep 30;43(17):8227-42. doi: 10.1093/nar/gkv721. Epub 2015 Jul 15.

6.

Proximity Utilizing Biotinylation of Nuclear Proteins in vivo.

Kulyyassov A, Zhubanova G, Ramanculov E, Ogryzko V.

Cent Asian J Glob Health. 2015 Jun 15;3(Suppl):165. doi: 10.5195/cajgh.2014.165. eCollection 2014.

7.

When an Intramolecular Disulfide Bridge Governs the Interaction of DUOX2 with Its Partner DUOXA2.

Carré A, Louzada RA, Fortunato RS, Ameziane-El-Hassani R, Morand S, Ogryzko V, de Carvalho DP, Grasberger H, Leto TL, Dupuy C.

Antioxid Redox Signal. 2015 Sep 20;23(9):724-33. doi: 10.1089/ars.2015.6265. Epub 2015 Apr 20.

8.

Molecular turnover, the H3.3 dilemma and organismal aging (hypothesis).

Saade E, Pirozhkova I, Aimbetov R, Lipinski M, Ogryzko V.

Aging Cell. 2015 Jun;14(3):322-33. doi: 10.1111/acel.12332. Epub 2015 Feb 26. Review.

9.

Comment on Masanari Asano et al.: A model of epigenetic evolution based on theory of open quantum systems.

Ogryzko V.

Syst Synth Biol. 2014 Jun;8(2):161-3. doi: 10.1007/s11693-013-9129-z. Epub 2013 Oct 24. No abstract available.

10.

In vivo Biotinylation Based Method for the Study of Protein-Protein Proximity in Eukaryotic Cells.

Kulyyassov A, Ramanculov E, Ogryzko V.

Cent Asian J Glob Health. 2014 Jan 24;2(Suppl):96. doi: 10.5195/cajgh.2013.96. eCollection 2013.

11.

Quantum biology at the cellular level--elements of the research program.

Bordonaro M, Ogryzko V.

Biosystems. 2013 Apr;112(1):11-30. doi: 10.1016/j.biosystems.2013.02.008. Epub 2013 Mar 5.

PMID:
23470561
12.

Distinct distribution of ectopically expressed histone variants H2A.Bbd and MacroH2A in open and closed chromatin domains.

Ioudinkova ES, Barat A, Pichugin A, Markova E, Sklyar I, Pirozhkova I, Robin C, Lipinski M, Ogryzko V, Vassetzky YS, Razin SV.

PLoS One. 2012;7(10):e47157. doi: 10.1371/journal.pone.0047157. Epub 2012 Oct 30.

13.

PUB-NChIP--"in vivo biotinylation" approach to study chromatin in proximity to a protein of interest.

Shoaib M, Kulyyassov A, Robin C, Winczura K, Tarlykov P, Despas E, Kannouche P, Ramanculov E, Lipinski M, Ogryzko V.

Genome Res. 2013 Feb;23(2):331-40. doi: 10.1101/gr.134874.111. Epub 2012 Oct 4.

14.

Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells.

Tolstorukov MY, Goldman JA, Gilbert C, Ogryzko V, Kingston RE, Park PJ.

Mol Cell. 2012 Aug 24;47(4):596-607. doi: 10.1016/j.molcel.2012.06.011. Epub 2012 Jul 12.

15.

Dualistic function of Daxx at centromeric and pericentromeric heterochromatin in normal and stress conditions.

Morozov VM, Gavrilova EV, Ogryzko VV, Ishov AM.

Nucleus. 2012 May-Jun;3(3):276-85. doi: 10.4161/nucl.20180. Epub 2012 May 1.

16.

3'-5' phosphoadenosine phosphate is an inhibitor of PARP-1 and a potential mediator of the lithium-dependent inhibition of PARP-1 in vivo.

Toledano E, Ogryzko V, Danchin A, Ladant D, Mechold U.

Biochem J. 2012 Apr 15;443(2):485-90. doi: 10.1042/BJ20111057.

17.

A vector design that allows fast and convenient production of differently tagged proteins.

Scapolan O, Mazzarello AN, Bono M, Occhino M, Ogryzko V, Bestagno M, Scartezzini P, Bruno S, Fais F, Ghiotto F.

Mol Biotechnol. 2012 Sep;52(1):16-25. doi: 10.1007/s12033-011-9469-4.

PMID:
22076571
18.

PUB-MS: a mass spectrometry-based method to monitor protein-protein proximity in vivo.

Kulyyassov A, Shoaib M, Pichugin A, Kannouche P, Ramanculov E, Lipinski M, Ogryzko V.

J Proteome Res. 2011 Oct 7;10(10):4416-27. doi: 10.1021/pr200189p. Epub 2011 Sep 2.

PMID:
21842862
19.

Use of in vivo biotinylation for chromatin immunoprecipitation.

Kulyyassov A, Shoaib M, Ogryzko V.

Curr Protoc Cell Biol. 2011 Jun;Chapter 17:Unit17.12. doi: 10.1002/0471143030.cb1712s51.

PMID:
21688254
20.

Exploring the use of dimethylsulfate for in vivo proteome footprinting.

Moio P, Kulyyassov A, Vertut D, Camoin L, Ramankulov E, Lipinski M, Ogryzko V.

Proteomics. 2011 Jan;11(2):249-60. doi: 10.1002/pmic.200900832. Epub 2010 Dec 15.

PMID:
21204252
21.

Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.

Perez RE, Knights CD, Sahu G, Catania J, Kolukula VK, Stoler D, Graessmann A, Ogryzko V, Pishvaian M, Albanese C, Avantaggiati ML.

J Cell Physiol. 2010 Nov;225(2):394-405. doi: 10.1002/jcp.22285.

22.

Use of high throughput sequencing to observe genome dynamics at a single cell level.

Parkhomchuk D, Amstislavskiy V, Soldatov A, Ogryzko V.

Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20830-5. doi: 10.1073/pnas.0906681106. Epub 2009 Nov 23.

23.

Analysis of interaction partners of H4 histone by a new proteomics approach.

Saade E, Mechold U, Kulyyassov A, Vertut D, Lipinski M, Ogryzko V.

Proteomics. 2009 Nov;9(21):4934-43. doi: 10.1002/pmic.200900206.

PMID:
19862764
24.

Degradation of nanoRNA is performed by multiple redundant RNases in Bacillus subtilis.

Fang M, Zeisberg WM, Condon C, Ogryzko V, Danchin A, Mechold U.

Nucleic Acids Res. 2009 Aug;37(15):5114-25. doi: 10.1093/nar/gkp527. Epub 2009 Jun 24.

25.

Multiple displacement amplification for complex mixtures of DNA fragments.

Shoaib M, Baconnais S, Mechold U, Le Cam E, Lipinski M, Ogryzko V.

BMC Genomics. 2008 Sep 15;9:415. doi: 10.1186/1471-2164-9-415.

26.

Use of protein biotinylation in vivo for immunoelectron microscopic localization of a specific protein isoform.

Viens A, Harper F, Pichard E, Comisso M, Pierron G, Ogryzko V.

J Histochem Cytochem. 2008 Oct;56(10):911-9. doi: 10.1369/jhc.2008.951624. Epub 2008 Jun 23.

27.

Erwin Schroedinger, Francis Crick and epigenetic stability.

Ogryzko VV.

Biol Direct. 2008 Apr 17;3:15. doi: 10.1186/1745-6150-3-15.

28.

Regulation of an inducible promoter by an HP1beta-HP1gamma switch.

Mateescu B, Bourachot B, Rachez C, Ogryzko V, Muchardt C.

EMBO Rep. 2008 Mar;9(3):267-72. doi: 10.1038/embor.2008.1. Epub 2008 Feb 1.

29.

YtqI from Bacillus subtilis has both oligoribonuclease and pAp-phosphatase activity.

Mechold U, Fang G, Ngo S, Ogryzko V, Danchin A.

Nucleic Acids Res. 2007;35(13):4552-61. Epub 2007 Jun 22.

30.

The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation.

Caretti G, Schiltz RL, Dilworth FJ, Di Padova M, Zhao P, Ogryzko V, Fuller-Pace FV, Hoffman EP, Tapscott SJ, Sartorelli V.

Dev Cell. 2006 Oct;11(4):547-60.

31.

High resolution characterization of formamidopyrimidine-DNA glycosylase interaction with its substrate by chemical cross-linking and mass spectrometry using substrate analogs.

Rogacheva M, Ishchenko A, Saparbaev M, Kuznetsova S, Ogryzko V.

J Biol Chem. 2006 Oct 27;281(43):32353-65. Epub 2006 Aug 22.

32.

Analysis of human histone H2AZ deposition in vivo argues against its direct role in epigenetic templating mechanisms.

Viens A, Mechold U, Brouillard F, Gilbert C, Leclerc P, Ogryzko V.

Mol Cell Biol. 2006 Jul;26(14):5325-35.

33.

Oligoribonuclease is a common downstream target of lithium-induced pAp accumulation in Escherichia coli and human cells.

Mechold U, Ogryzko V, Ngo S, Danchin A.

Nucleic Acids Res. 2006 May 8;34(8):2364-73. Print 2006.

34.
35.

Coactivators p300 and PCAF physically and functionally interact with the foamy viral trans-activator.

Bannert H, Muranyi W, Ogryzko VV, Nakatani Y, Flügel RM.

BMC Mol Biol. 2004 Sep 6;5:16.

36.

Use of protein biotinylation in vivo for chromatin immunoprecipitation.

Viens A, Mechold U, Lehrmann H, Harel-Bellan A, Ogryzko V.

Anal Biochem. 2004 Feb 1;325(1):68-76.

PMID:
14715286
37.

Immunoaffinity purification of mammalian protein complexes.

Nakatani Y, Ogryzko V.

Methods Enzymol. 2003;370:430-44. No abstract available.

PMID:
14712665
38.

Chromatin dynamics and DNA repair.

Ikura T, Ogryzko VV.

Front Biosci. 2003 Jan 1;8:s149-55. Review.

PMID:
12456295
39.

The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2.

Decary S, Decesse JT, Ogryzko V, Reed JC, Naguibneva I, Harel-Bellan A, Cremisi CE.

Mol Cell Biol. 2002 Nov;22(22):7877-88.

40.

Ssdp proteins interact with the LIM-domain-binding protein Ldb1 to regulate development.

Chen L, Segal D, Hukriede NA, Podtelejnikov AV, Bayarsaihan D, Kennison JA, Ogryzko VV, Dawid IB, Westphal H.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14320-5. Epub 2002 Oct 15.

41.

Metastable macromolecular complexes containing high mobility group nucleosome-binding chromosomal proteins in HeLa nuclei.

Lim JH, Bustin M, Ogryzko VV, Postnikov YV.

J Biol Chem. 2002 Jun 7;277(23):20774-82. Epub 2002 Mar 21.

42.

The p400 complex is an essential E1A transformation target.

Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V, Lane WS, Nakatani Y, Livingston DM.

Cell. 2001 Aug 10;106(3):297-307.

43.

Mammalian histone acetyltransferases and their complexes.

Ogryzko VV.

Cell Mol Life Sci. 2001 May;58(5-6):683-92. Review.

PMID:
11437230
44.

Mammalian histone acetyltransferase complexes.

Ogryzko V.

Medicina (B Aires). 2000;60 Suppl 2:21-6.

PMID:
11188926
45.

Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.

Li M, Damania B, Alvarez X, Ogryzko V, Ozato K, Jung JU.

Mol Cell Biol. 2000 Nov;20(21):8254-63.

46.

Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis.

Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J, Nakatani Y.

Cell. 2000 Aug 18;102(4):463-73.

48.

p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation.

Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L, Ogryzko V, Avantaggiati ML, Pestell RG.

J Biol Chem. 2000 Jul 7;275(27):20853-60.

49.

An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression.

Rubinstein YR, Driggers PH, Ogryzko VV, Thornton AM, Ozato K, Pontzer CH.

Oncogene. 2000 Mar 9;19(11):1411-8.

50.

Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program.

Sartorelli V, Puri PL, Hamamori Y, Ogryzko V, Chung G, Nakatani Y, Wang JY, Kedes L.

Mol Cell. 1999 Nov;4(5):725-34.

Supplemental Content

Loading ...
Support Center